Sally Beauty entered the first quarter with strong momentum, driven by consistent, comparable sales growth in its key segments.

TWLO's Q4 results are likely to reflect the benefits of AI integration, deepened collaborations, customer additions and cost-cutting measures.

Kevin Hincks keeps tech top of mind on today's Daily Trader as Supermicro (SMCI) readies for its business update at the close. He also turns to an example options trade in Microsoft (MSFT), which slipped 10% since hitting its all-time high last July.

Shopify Inc. (NYSE:SHOP ) Q4 2024 Earnings Conference Call February 11, 2025 8:30 AM ET Company Participants Carrie Gillard - Director of Investor Relations Harley Finkelstein - President Jeff Hoffmeister - Chief Financial Officer Conference Call Participants Andrew Bauch - Wells Fargo Securities Jeff Cantwell - Seaport Research Craig Maurer - Financial Technology Partners Mark Mahaney - Evercore ISI Bradley Sills - Bank of America Securities Gabriela Borges - Goldman Sachs Mark Zgutowicz - Benchmark Paul Treiber - RBC Capital Markets Colin Sebastian - Baird Carrie Gillard Good morning and thank you for joining Shopify's Fourth Quarter 2024 Conference Call. …

Gold (GC=F) prices hit record highs amid fears of a global trade war, with tariffs on steel and aluminum driving gold prices above $2,900 Monday. Yahoo Finance Senior Business Reporter Ines Ferré joins Morning Brief break down the details, noting that gold hit eight all-time highs this year and is up 10% year to date.

Meta is in talks to acquire South Korean AI chip startup FuriosaAI, according to people familiar with the matter, a deal that could boost the social media giant's custom chip efforts amid a shortage of Nvidia chips and a growing demand for alternatives.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ:KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc., a biotechnology company developing lysosomal targeting chimera (LYTAC)-based protein degradation therapies to eliminate disease at its source, today announced the appointment of Chin Lee, M.D.

The luxury brand will showcase the future of design and function through new innovations and exclusive collaborations BENTON HARBOR, Mich. , Feb. 11, 2025 /PRNewswire/ -- JennAir is set to unveil its latest innovations at the 2025 Kitchen and Bath Industry Show (KBIS), continuing its legacy of pushing the boundaries of luxury design and performance in the kitchen.

NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MGP Ingredients, Inc. (NASDAQ: MGPI) between May 4, 2023 and October 30, 2024 (the “Class Period”), of the important February 14, 2025 lead plaintiff deadline.

GlobalFoundries, Inc. (NASDAQ:GFS ) Q4 2024- Earnings Conference Call February 11, 2025 8:30 AM ET Company Participants Sam Franklin - VP, Business Finance & IR Thomas Caulfield - CEO John Hollister - CFO Niels Anderskouv – CBO Tim Breen - COO Conference Call Participants Chris Caso - Wolfe Research Mark Lipacis - Evercore ISI Krish Sankar - TW Cowen Ross Seymore - Deutsche Bank Harlan Sur - J.P. Morgan Vivek Arya - Bank of America Securities Quinn Bolton - Needham & Company Operator Good day and thank you for standing by.

Meta Platforms (NASDAQ:META) and Amazon (NASDAQ:AMZN) continue to be among the top so-called “Magnificent 7” stocks in the market, with valuations well above the $1 trillion threshold.

INDIANA, Pa., Feb. 11, 2025 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp Inc. (NASDAQ: STBA), is proud to announce being named to the Forbes America's Best Banks list for the second consecutive year.

Apple reportedly found a partner to help it bring its artificial intelligence features to devices in China. The iPhone maker is working with Chinese tech giant Alibaba to develop and launch its Apple Intelligence AI offering in the crucial market, The Information reported Tuesday (Feb. 11), citing an unnamed source.

AppLovin (NASDAQ:APP) is a mobile app publisher and developer of AI-driven monetization tools that's seen a strong rebound over the past year, as investors piled into companies that have the ability to accelerate ad spending and adoption.

Leading automotive digital agency now supports dealership websites by managing millions of visitors monthly with a modernized cloud infrastructure Leading automotive digital agency now supports dealership websites by managing millions of visitors monthly with a modernized cloud infrastructure

Despite the high adoption of air pollution control equipment, the growing preference for alternative fuels and the high costs of innovation are limiting the prospects for the Zacks Pollution Control industry. DCI, CECO, ERII and FTEK are four stocks to consider.

Positron, a startup chip maker that aims to compete with Nvidia , said Tuesday it raised $23.5 million to scale production of its U.S.-made artificial intelligence chips.

Compass Minerals International (CMP -4.12%), a leader in salt and specialty plant nutrition production, delivered a mixed report for its fiscal 2025 first quarter on Feb. 10. The company's non-GAAP loss of $0.55 per share contrasted with the earnings per share (EPS) of $0.13 anticipated by analysts.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX) concerning possible violations of federal securities laws. On February 7, 2025, Pliant announced that following a prespecified data review and recommendations by the trial's independent Data Safety Monitoring Board, it had voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis.